(9) described the ability of FAP+ cells to suppress the anti-tumor immune response, which they evaluated using a transgenic mouse model in which the FAP gene was modified to include coding sequences for green fluorescent protein or diphtheria toxin receptor. This evidence concerns the gene HBEGF and neoplasm.